Abstract
Get full access to this article
View all access options for this article.
References
1.
Kim
SM
Waters
P
Woodhall
M
. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders . Mult Scler 2013 ; 19 : 1060 -1067 .
2.
Wingerchuk
DM
Lennon
VA
Lucchinetti
CF
. The spectrum of neuromyelitis optica . Lancet Neurol 2007 ; 6 : 805 –815 .
3.
Canellas
AR
Gols
AR
Izquierdo
JR
. Idiopathic inflammatory-demyelinating diseases of the central nervous system . Neuroradiology 2007 ; 49 : 393 –409 .
4.
Sato
DK
Nakashima
I
Takahashi
T
. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders . Neurology 2013 ; 80 : 2210 –2216 .
5.
Jiao
Y
Fryer
JP
Lennon
VA
. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica . Neurology 2013 ; 81 : 1197 –1204 .
6.
Siritho
S
Nakashima
I
Takahashi
T
. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems . Neurology 2011 ; 77 : 827 –834 .
7.
Wingerchuk
DM
Lennon
VA
Pittock
SJ
. Revised diagnostic criteria for neuromyelitis optica . Neurology 2006 ; 66 : 1485 –1489 .